This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on Web of Science (14)  • Contact me when this article is cited  Related Content  • Related articles  • Similar articles in this journal  Topic Collections  • Dermatologic Disorders  • Connective Tissue Diseases  • Dermatologic Disorders, Other  • Alert me on articles by topic  Social Bookmarking   What's this?

Dan M. Lipsker, MD; Catherine Schreckenberg-Gilliot, MD; Béatrice Uring-Lambert, MD, PhD; Alice Meyer; Dominique Hartmann; Edouard M. Grosshans, MD; Georges Hauptmann, MD, PhD

Arch Dermatol. 2000;136:1508-1514.

Background  The gene deletion responsible for the type I human complement C2 deficiency was reported in 1992. The purpose of our study is to evaluate clinical and immunological characteristics of 11 patients with lupus erythematosus and type I C2 deficiency.

Observations  We observed 5 patients with a homozygous C2 deficiency and 6 with a heterozygous C2 deficiency. Eight patients had systemic lupus erythematosus, 2 had subacute cutaneous lupus erythematosus, and 1 had chronic lupus erythematosus. Photosensitivity was present in 73% of the patients, and 64% tested positive for anti-Ro (SSA) antibodies. Renal involvement that required immunosuppressive therapy was present in 54% of the patients. Ninety percent of the patients tested positive for antinuclear antibodies, and 54% tested positive for anti–double-stranded DNA antibodies. Phenotyping of the fourth component of the complement was performed in 82% of the patients and showed a C4A4B2 phenotype, which is suggestive for the type I C2 deficiency.

Conclusions  Most patients with lupus erythematosus associated with C2 type I deficiency are photosensitive, and this is probably related to the presence of anti-Ro (SSA) autoantibodies. The prognosis for those patients is not better than that for patients with lupus erythematosus in general.

From the Clinique Dermatologique (Drs Lipsker, Schreckenberg-Gilliot, and Grosshans) and Laboratoire d'Immuno-Hématologie des Hôpitaux (Drs Uring-Lambert and Hauptmann and Mss Meyer and Hartmann), Universitaires de Strasbourg, Strasbourg, France.

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

RELATED ARTICLES

Detection of Type 1 Cytokines in Discoid Lupus Erythematosus
Jorge R. Toro, Deborah Finlay, Xiaogin Dou, Shi Chun Zheng, Philip E. LeBoit, and M. Kari Connolly
Arch Dermatol. 2000;136(12):1497-1501.
ABSTRACT | FULL TEXT  

Archives of Dermatology Reader's Choice: Continuing Medical Education
Arch Dermatol. 2000;136(12):1578-1579.
FULL TEXT  

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Complement and its breakdown products in SLE
Sturfelt and Truedsson
Rheumatology (Oxford) 2005;44:1227-1232.
ABSTRACT | FULL TEXT